SCR-LIP-000282 · Claim · machine-readable JSON →
A systematic review of molecular and cellular lipedema research estimated worldwide prevalence at approximately 11% among women, noting this figure is inflated by underdiagnosis and acknowledged diagnostic limitations, but the review focused on molecular biology and did not evaluate screening tools.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema Research—Quo Vadis? — Ernst et al. (2023) ✓ verified — contextual · review · 2023 · reading confidence: high
“Prevalência mundial estimada em 11% entre mulheres — dado ampliado por subdiagnóstico, mas com limitação diagnóstica reconhecida pelos autores”
The review mentions underdiagnosis ('subdiagnóstico') as a factor inflating prevalence estimates, which provides contextual support for underdiagnosis, but it does not directly study or evaluate any screening tools; its primary focus is mol
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? contextual
- Is lipedema underdiagnosed, misdiagnosed, or diagnosed late? contextual
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000004